These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10667618)

  • 1. A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.
    Søgaard J; Lane R; Latimer P; Behnke K; Christiansen PE; Nielsen B; Ravindran AV; Reesal RT; Goodwin DP
    J Psychopharmacol; 1999 Dec; 13(4):406-14. PubMed ID: 10667618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
    J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP; Søgaard J; Roponen P; Behnke K
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.
    Atmaca M; Kuloglu M; Tezcan E; Unal A
    Hum Psychopharmacol; 2002 Dec; 17(8):401-5. PubMed ID: 12457375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study of sertraline in patients with major depression who failed to respond to moclobemide.
    George T; Theodoros MT; Chiu E; Krapivensky N; Hokin A; Tiller JW
    Aust N Z J Psychiatry; 1999 Dec; 33(6):889-95. PubMed ID: 10619217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
    Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
    Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
    Ravindran AV; Guelfi JD; Lane RM; Cassano GB
    J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
    Suri RA; Altshuler LL; Rasgon NL; Calcagno JL; Frye MA; Gitlin MJ; Hwang S; Zuckerbrow-Miller J
    J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
    Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
    Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
    Mulholland C; Lynch G; King DJ; Cooper SJ
    J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms.
    Curtin F; Berney P; Kaufmann C
    J Psychopharmacol; 2002 Sep; 16(3):271-2. PubMed ID: 12236637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
    Philipp M; Tiller JW; Baier D; Kohnen R
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):305-14. PubMed ID: 10974600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
    Lonnqvist J; Sintonen H; Syvälahti E; Appelberg B; Koskinen T; Mannikko T; Mehtonen OP; Naarala M; Sihvo S; Auvinen J
    Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
    Finkel SI; Richter EM; Clary CM
    Int Psychogeriatr; 1999 Mar; 11(1):85-99. PubMed ID: 10189602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.